{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:24:17Z","timestamp":1741238657224,"version":"3.38.0"},"reference-count":6,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Dermatol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1684\/ejd.2019.3518","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:25:00Z","timestamp":1696865100000},"page":"229-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Intravenous immunoglobulins for delayed wound healing associated with toxic epidermal necrolysis"],"prefix":"10.1684","volume":"29","author":[{"given":"Laure","family":"Dequidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Sophie","family":"Darrigade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibault","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"3518_CR1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.4103\/0378-6323.191134","volume":"82","author":"LK Gupta","year":"2016","unstructured":"Gupta LK, Martin AM, Agarwal N, et al. Guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis: an Indian perspective. Indian J Dermatol Venereol Leprol 2016;82:603\u201325.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"3518_CR2","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1111\/ijd.13156","volume":"55","author":"D Mehregan","year":"2016","unstructured":"Mehregan D, Van Vreede A, Goralewski M. Toxic epidermal necrolysis treatment and outcomes: a retrospective analysis of 10 patients treated with intravenous immunoglobulin. Int J Dermatol 2016;55:e356\u201360.","journal-title":"Int J Dermatol"},{"key":"3518_CR3","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"53","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, et al. Systemic immunomod-ulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 2017;53:514\u201322.","journal-title":"JAMA Dermatol"},{"key":"3518_CR4","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/jdv.13725","volume":"30","author":"AH Enk","year":"2016","unstructured":"Enk AH, Hadaschik EN, Eming R, et al. European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology. J Eur Acad Dermatol Venereol 2016;30:1657\u201369.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3518_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","volume":"124","author":"ED Renner","year":"2009","unstructured":"Renner ED, Hartl D, Rylaarsdam S, et al. Com\u00e8l-Netherton syndrome defined as primary immunodeficiency. J Allergy Clin Immunol 2009;124:536\u201343.","journal-title":"J Allergy Clin Immunol"},{"key":"3518_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","volume":"27","author":"V-S Negi","year":"2007","unstructured":"Negi V-S, Elluru S, Sib\u00e9ril S, et al. Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 2007;27:233\u201345.","journal-title":"J Clin Immunol"}],"container-title":["European Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1684\/ejd.2019.3518\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1684\/ejd.2019.3518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:19:43Z","timestamp":1741191583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/ejd.2019.3518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["3518"],"URL":"https:\/\/doi.org\/10.1684\/ejd.2019.3518","relation":{},"ISSN":["1952-4013"],"issn-type":[{"type":"electronic","value":"1952-4013"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"27 Mai 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}